Clinical trials: Eating Disorder Not Otherwise Specified, BMI (<=18)

Anxiety in Those Patients With Anorexia Nervosa, Eating Disorder Not Otherwise Specified, BMI (<=18)

Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder

• Withdrawn
• Age: 8 to 25 years
• Phase 4

The purpose of this study is to determine the effectiveness of hydroxyzine in the treatment of meal-related anxiety in adolescents and young adults 8 to 25 years of age diagnosed with an eating disorder who are underweight.

Trial name

NCT01372670

Testing

Hydroxyzine, hydroxyzine HCL

Where

United States

Sponsor

HealthPartners Institute